IndraLab

Statements


USP53 deubiquitinates FKBP4. 6 / 6
| 6

reach
"USP53 is lowly expressed in lung adenocarcinoma, and USP53 deubiquitinates FKBP51, which thereby inhibits tumor growth in lung adenocarcinoma (72).2.5 Ubiquitination enzyme and the treatment of LC."

reach
"As a tumour suppressor, USP53 can deubiquitinate FK506-binding protein 51 (FKBP51) to dephosphorylate AKT1 and inactivate downstream signalling pathways, thereby inhibiting the progression of LUAD (98)."

reach
"USP53 deubiquitinated FKBP51 in lung adenocarcinoma cells (H1975 and HCC827), which, in turn, dephosphorylated AKT1, inducing cell apoptosis and inhibiting glycolysis through this signaling pathway."

reach
"Besides, USP53 could also induce cell apoptosis in lung adenocarcinoma cells through deubiquitinating FKBP51 [8]."

reach
"Lung adenocarcinoma cells are regulated by USP53, which deubiquitinates FKBP51, dephosphorylates AKT1, and controls glycolysis and apoptosis [10]."

reach
"Mechanistically, USP53 deubiquitinates FKBP51, which in turn dephosphorylates AKT1, and ultimately inhibits tumor growth in lung adenocarcinoma."